
VeraDermics Inc (MANE) Earnings Dates & Reports
VeraDermics Inc (MANE) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS-$0.66
Actual EPS-$0.62
EarningsBeat
VeraDermics Inc (MANE) Earnings
View the latest VeraDermics Inc (MANE) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in VeraDermics Inc (MANE)
Order type
Buy in
Order amount
Est. shares
0 shares
VeraDermics Inc (MANE) Earnings per Share (EPS) History
Signup for full accessBrowse free
VeraDermics Inc (MANE) Latest Earnings
The value each MANE share was expected to gain vs. the value each share gained.
VeraDermics Inc (MANE) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.62. This exceeded analysts' expectations of -$0.66 by 6.06%, marking a Beat.
For comparison, VeraDermics Inc reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.64.
VeraDermics Inc (MANE) Earnings History
VeraDermics Inc (MANE) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the VeraDermics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — |
VeraDermics Inc (MANE) Earnings FAQs
VeraDermics Inc (MANE) last reported earnings on Mar 30, 2026 for Q4 2025, posting an EPS of -$0.62, which Beat the estimate of -$0.66 by 6.06%.
For Q4 2025, VeraDermics Inc (MANE) reported an EPS of -$0.62, exceeding analysts' estimate of -$0.66 by 6.06%.
For Q4 2025, VeraDermics Inc (MANE) Beat expectations with an actual EPS of -$0.62 vs. an estimated EPS of -$0.66.
Following the last earnings report on Mar 30, 2026, VeraDermics Inc (MANE)'s stock price moved — from — to —.
The next VeraDermics Inc (MANE) earnings call is scheduled for Aug. 6, 2026, where executives will discuss financial results and outlook.